S. Kuwakado

Epidermal growth factor receptor is a possible predictor of sensitivity to chemoradiotherapy in the primary lesion of esophageal squamous cell carcinoma.

M. Gotoh, H. Takiuchi, T. Kii, 2007, Japanese journal of clinical oncology.

Retrospective Study as First-Line Chemotherapy Combined Anti-VEGF Antibody with Fluoropyrimidine for Frail Patients with Unresectable or Metastatic Colorectal Cancer

K. Higuchi, T. Kii, M. Goto, 2013, Digestion.

Impact of modified FOLFOX‐6 for patients with gastric cancer and a gastrointestinal obstruction

K. Higuchi, T. Kii, M. Aoki, 2018, Asia-Pacific journal of clinical oncology.

Evaluation of prognostic factors of esophageal squamous cell carcinoma (stage II-III) after concurrent chemoradiotherapy using biopsy specimens.

M. Gotoh, H. Takiuchi, T. Kii, 2007, Japanese journal of clinical oncology.

Efficacy of Prophylactic G-CSF in Patients Receiving FOLFIRINOX: A Preliminary Retrospective Study.

K. Higuchi, T. Kii, M. Goto, 2015, Internal medicine.

Front & Back Matter

Y. Imai, K. Chayama, Furhawn A. Shah, 2013, Digestion.

Efficacy of Prophylactic G-CSF in Patients Receiving FOLFIRINOX: A Preliminary Retrospective Study.

K. Higuchi, T. Kii, M. Goto, 2015, Internal medicine.